Predictors of the placebo response in clinical trials on Parkinson’s disease: A meta-analysis
- 20 May 2016
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 29, 83-89
- https://doi.org/10.1016/j.parkreldis.2016.05.019
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Nocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta‐analysisEuropean Journal of Neurology, 2012
- A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic SitesNeuropsychopharmacology, 2012
- Placebo-Induced Improvements: How Therapeutic Rituals Affect the Patient's BrainJournal of Acupuncture and Meridian Studies, 2012
- The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's diseaseMovement Disorders, 2011
- The Nocebo Effect and Its Relevance for Clinical PracticePsychosomatic Medicine, 2011
- Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventionsMovement Disorders, 2008
- The placebo effect in neurological disordersThe Lancet Neurology, 2002
- Placebo Response in Studies of Major DepressionJAMA, 2002
- Placebo‐associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's diseaseMovement Disorders, 2002
- Objective changes in motor function during placebo treatment in PDNeurology, 2000